Adagio Medical (ADGM) Competitors

Adagio Medical logo
$1.75 +0.09 (+5.42%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.00 (+0.11%)
As of 11/20/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADGM vs. KRMD, INGN, TLSI, OWLT, and FOCL

Should you buy Adagio Medical stock or one of its competitors? Adagio Medical's main competitors and comparable companies include KORU Medical Systems (KRMD), Inogen (INGN), TriSalus Life Sciences (TLSI), Owlet (OWLT), and FocalTherics (FOCL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Adagio Medical compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

In the previous week, KORU Medical Systems and KORU Medical Systems both had 2 articles in the media. Adagio Medical's average media sentiment score of 1.50 beat KORU Medical Systems' score of 0.30 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 8.9% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Adagio Medical has a net margin of 0.00% compared to KORU Medical Systems' net margin of -1.78%. Adagio Medical's return on equity of 13.92% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-1.78% -4.62% -2.90%
Adagio Medical N/A 13.92%2.12%

KORU Medical Systems currently has a consensus price target of $6.50, indicating a potential upside of 104.15%. Adagio Medical has a consensus price target of $105.00, indicating a potential upside of 5,900.00%. Given Adagio Medical's higher possible upside, analysts plainly believe Adagio Medical is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

KORU Medical Systems has higher revenue and earnings than Adagio Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.36-$2.64M-$0.02N/A
Adagio Medical$600K80.76-$25.08M-$29.75N/A

KORU Medical Systems has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market.

Summary

KORU Medical Systems beats Adagio Medical on 8 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Inogen?

Inogen (NASDAQ:INGN) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

Inogen has higher revenue and earnings than Adagio Medical. Inogen is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$348.67M0.40-$22.75M-$1.31N/A
Adagio Medical$600K80.76-$25.08M-$29.75N/A

In the previous week, Adagio Medical had 1 more articles in the media than Inogen. MarketBeat recorded 2 mentions for Adagio Medical and 1 mentions for Inogen. Adagio Medical's average media sentiment score of 1.50 beat Inogen's score of 0.35 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inogen
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Adagio Medical has a consensus price target of $105.00, indicating a potential upside of 5,900.00%. Given Adagio Medical's higher probable upside, analysts clearly believe Adagio Medical is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Inogen has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.07, meaning that its stock price is 93% less volatile than the broader market.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 8.9% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to Inogen's net margin of -10.46%. Adagio Medical's return on equity of 13.92% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-10.46% -19.29% -12.02%
Adagio Medical N/A 13.92%2.12%

Summary

Adagio Medical beats Inogen on 10 of the 17 factors compared between the two stocks.

How does Adagio Medical compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

In the previous week, TriSalus Life Sciences had 9 more articles in the media than Adagio Medical. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.50 beat TriSalus Life Sciences' score of 0.55 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TriSalus Life Sciences
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

TriSalus Life Sciences has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.07, suggesting that its stock price is 93% less volatile than the broader market.

Adagio Medical has lower revenue, but higher earnings than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$45.15M3.16-$39.23M-$0.49N/A
Adagio Medical$600K80.76-$25.08M-$29.75N/A

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by company insiders. Comparatively, 8.9% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -56.60%. Adagio Medical's return on equity of 13.92% beat TriSalus Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-56.60% N/A -55.00%
Adagio Medical N/A 13.92%2.12%

TriSalus Life Sciences presently has a consensus target price of $9.20, indicating a potential upside of 296.55%. Adagio Medical has a consensus target price of $105.00, indicating a potential upside of 5,900.00%. Given Adagio Medical's higher possible upside, analysts plainly believe Adagio Medical is more favorable than TriSalus Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Adagio Medical beats TriSalus Life Sciences on 9 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Owlet?

Adagio Medical (NASDAQ:ADGM) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Adagio Medical has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, Owlet has a beta of 2.17, indicating that its stock price is 117% more volatile than the broader market.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 8.9% of Adagio Medical shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to Owlet's net margin of -11.11%. Adagio Medical's return on equity of 13.92% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A 13.92% 2.12%
Owlet -11.11%-53.97%-13.77%

Adagio Medical currently has a consensus target price of $105.00, suggesting a potential upside of 5,900.00%. Owlet has a consensus target price of $12.00, suggesting a potential upside of 306.78%. Given Adagio Medical's higher possible upside, equities research analysts clearly believe Adagio Medical is more favorable than Owlet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Owlet
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Adagio Medical has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K80.76-$25.08M-$29.75N/A
Owlet$105.70M0.83-$39.68M-$0.68N/A

In the previous week, Owlet had 6 more articles in the media than Adagio Medical. MarketBeat recorded 8 mentions for Owlet and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.50 beat Owlet's score of 0.32 indicating that Adagio Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Adagio Medical and Owlet tied by winning 8 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to FocalTherics?

Adagio Medical (NASDAQ:ADGM) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 8.9% of Adagio Medical shares are owned by insiders. Comparatively, 10.1% of FocalTherics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to FocalTherics' net margin of -59.77%. Adagio Medical's return on equity of 13.92% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A 13.92% 2.12%
FocalTherics -59.77%-223.32%-41.32%

In the previous week, Adagio Medical had 2 more articles in the media than FocalTherics. MarketBeat recorded 2 mentions for Adagio Medical and 0 mentions for FocalTherics. Adagio Medical's average media sentiment score of 1.50 beat FocalTherics' score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company Overall Sentiment
Adagio Medical Very Positive
FocalTherics Neutral

Adagio Medical has higher earnings, but lower revenue than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K80.76-$25.08M-$29.75N/A
FocalTherics$70.53M1.39-$29.25M-$0.98N/A

Adagio Medical currently has a consensus price target of $105.00, suggesting a potential upside of 5,900.00%. FocalTherics has a consensus price target of $9.67, suggesting a potential upside of 270.37%. Given Adagio Medical's higher probable upside, equities research analysts clearly believe Adagio Medical is more favorable than FocalTherics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Adagio Medical has a beta of 0.07, suggesting that its stock price is 93% less volatile than the broader market. Comparatively, FocalTherics has a beta of -0.02, suggesting that its stock price is 102% less volatile than the broader market.

Summary

Adagio Medical beats FocalTherics on 11 of the 17 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.72M$5.99B$7.75B$11.70B
Dividend YieldN/A1.69%2.48%4.66%
P/E RatioN/A38.2132.5328.82
Price / Sales2.865.427.905.32
Price / CashN/A23.7921.0521.90
Price / Book0.094.014.263.50
Net Income-$25.08M$143.06M$3.51B$394.12M
1 Month Performance-49.41%-8.30%-10.59%-12.04%
1 Year Performance-92.62%-4.45%-4.80%-11.42%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
2.4026 of 5 stars
$1.75
+5.4%
$105.00
+5,900.0%
-92.6%$1.72M$600KN/A41
KRMD
KORU Medical Systems
3.7418 of 5 stars
$3.87
+22.5%
$6.50
+68.0%
-27.6%$173.81M$45.11MN/A73
INGN
Inogen
0.9373 of 5 stars
$5.76
-4.0%
N/A-19.5%$152.15M$348.67MN/A753
TLSI
TriSalus Life Sciences
3.6062 of 5 stars
$2.29
-19.8%
$9.20
+302.6%
-53.2%$141.82M$45.15MN/A102
OWLT
Owlet
3.3285 of 5 stars
$4.57
+5.4%
$15.00
+227.9%
-75.3%$133.54M$105.70MN/A114

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners